title: A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation.
abstract: OBJECTIVE
  To develop an immunomagnetic cell separation system for allogeneic hematopoietic stem cell (HSC) transplantations, which can achieve a high level of T-cell depletion (at least 4.0 log(10)), high level of recovery of hematopoietic stem cells (>90%), with a high throughput (>10(6) cells/second).
  
  
  METHODS
  Peripheral blood leukocytes (PBLs) from buffy coats were spiked with CD34-expressing cells (KG1a) to mimic a leukaphoresis product containing stimulated HSCs. T cells were labeled with anti-CD3(+) Dynabeads and separated in a quadrupole magnetic cell sorter (QMS). The performance of the system with respect to T-cell depletion and recovery of non-T cells and spiked KG1a was determined using four-color, flow cytometry analysis, with the aid of Trucount cell-concentration calibration beads. Limiting dilution assays were also performed to quantify the log(10) depletion of clonable T cells.
  
  
  RESULTS
  While the general performance of the QMS system is governed by proven theoretical principles, significant system variability exist, not all of which can be explained by our current understanding. Consequently, a factorial design was employed, guided by JMP software, to optimize the labeling conditions and operation of the QMS focused on maximizing the depletion of T cell, and recovery of unlabeled cells including KG1a cells. From these studies, an optimized, no wash, immunomagnetic labeling protocol and optimized QMS operating conditions were developed. For an average initial cell concentration of 1.7 x 10(8) total cells, an average 3.96 +/- 0.33 log(10) depletion (range, 3.53-4.34) of CD3(+)CD45(+) cells with a mean 99.43% +/- 4.23% recovery of CD34(+)CD45(+) cells (range, 94.38-104.90%) was achieved at a sorting speed of 10(6) cells/s (n = 6). Limiting dilution assays on the T-cell depleted fractions, which gave a log(10) depletion of 3.51 for the clonable T cells.
  
  
  CONCLUSIONS
  We suggest that this system will provide superior performance with respect to T-cell depletion and CD34(+) recovery for clinical allogeneic bone marrow transplants. Ongoing studies, on a clinical scale, are being conducted to demonstrate this claim.
authors: Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus Ohio, USA.
authors: Xiaodong
authors: X
authors: Tong
authors: Ying
authors: Y
authors: Xiong
authors: Maciej
authors: M
authors: Zborowski
authors: Sherif S
authors: SS
authors: Farag
authors: Jeffrey J
authors: JJ
authors: Chalmers
mesh_terms: D018952:Antigens, CD34 / Q000096:biosynthesis; D017252:CD3 Complex / Q000096:biosynthesis; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D018189:Immunomagnetic Separation / Q000295:instrumentation / Q000592:standards; D007519:Isoantigens / Q000096:biosynthesis; D017493:Leukocyte Common Antigens / Q000096:biosynthesis; D007962:Leukocytes / Q000166:cytology* / Q000378:metabolism; D008212:Lymphocyte Depletion / Q000295:instrumentation / Q000592:standards; D036102:Peripheral Blood Stem Cell Transplantation; D012015:Reference Standards; D015203:Reproducibility of Results; D014184:Transplantation, Homologous
chemical_list: D018952:Antigens, CD34; D017252:CD3 Complex; D007519:Isoantigens; C060224:Kg, red cell antigen; D017493:Leukocyte Common Antigens; C516769:PTPRC protein, human
references: Transplantation. 1985 Sep;40(3):317-22
references: 3875918
references: J Immunol. 1981 Apr;126(4):1614-9
references: 7009746
references: Blood. 1992 Jun 15;79(12):3380-7
references: 1596577
references: Blood. 1994 Dec 1;84(11):3948-55
references: 7524753
references: Bone Marrow Transplant. 1997 Jun;19(11):1069-77
references: 9193748
references: Transplantation. 1997 Aug 15;64(3):472-9
references: 9275115
references: Bone Marrow Transplant. 1997 Oct;20(7):599-605
references: 9337063
references: N Engl J Med. 1998 Oct 22;339(17):1186-93
references: 9780338
references: J Immunol Methods. 1999 May 27;225(1-2):113-24
references: 10365788
references: Springer Semin Immunopathol. 2004 Nov;26(1-2):155-68
references: 15378270
references: Klin Padiatr. 2005 Nov-Dec;217(6):334-8
references: 16307419
references: Biotechnol Bioeng. 2006 May 5;94(1):66-80
references: 16518837
references: Cytotherapy. 2006;8(5):465-72
references: 17050251
references: Exp Hematol. 2007 Apr;35(4):662-72
references: 17379076
references: Clin Lab Haematol. 1999 Oct;21(5):301-8
references: 10646072
references: Bone Marrow Transplant. 2000 Jun;25(12):1223-8
references: 10871725
references: Transfusion. 2000 Dec;40(12):1475-81
references: 11134567
references: J Chromatogr A. 2000 Dec15;903(1-2):99-116
references: 11153960
references: Bone Marrow Transplant. 2001 Apr;27(7):683-7
references: 11360106
references: Cytotherapy. 2001;3(6):467-81
references: 11953031
references: Bone Marrow Transplant. 2002 Jul;30(2):69-74
references: 12132044
references: Transplantation. 2002 Aug 27;74(4):562-70
references: 12352920
references: Bone Marrow Transplant. 2003 May;31(10):857-60
references: 12748661
references: Biol Blood Marrow Transplant. 2003 Oct;9(10):633-42
references: 14569559
references: Br J Haematol. 2004 Jan;124(1):72-9
references: 14675410
references: Cytotherapy. 2004;6(1):1-6
references: 14985161
references: Exp Hematol. 2004 Oct;32(10):891-904
references: 15504544
references: Blood. 1990 Mar 15;75(6):1356-63
references: 2310832